From: Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients
Variable | Non-thalassemic | Thalassemic | P-valuea |
---|---|---|---|
Gender (n) | |||
Females | 16 | 15 | 0.515 |
Males | 23 | 29 | |
Total | 39 | 44 | |
Age (mean ± SD)b | 24.59 ± 8.165 | 23.41 ±7.916 | 0.506 |
Hb, g/dl (mean ± SD)b | 14.5 ± 1.42 | 7.8 ± 0.71 | < 0.0001 |
EPO, ng/ml (mean ± SD)b | 137.7 ± 81.5 | 638.4 ± 272.3 | < 0.0001 |
Estrogen or testosterone, ng/ml (Mean ± SD)b | 2.7 ± 0.9 | 0.63 ± 0.44 | < 0.0001 |
OPG, pg/ml (mean ± SD)b | 3931.2 ± 479.8 | 3370 ± 1142.4 | 0.004 |
RANKL, pg/ml (mean ± SD)b | 2621.9 ± 578.9 | 4980.9 ± 1313.6 | < 0.0001 |
RANKL/OPG ratio (mean ± SD)b | 0.7 ± 0.22 | 1.66 ± 0.85 | < 0.0001 |
P1NP, pg/ml (mean ± SD)b | 269.4 ± 127.7 | 64.4 ± 52 | < 0.0001 |
CTX, pg/ml (mean ± SD)b | 185.9 ± 53.6 | 459.2 ± 120.1 | < 0.0001 |